Your browser doesn't support javascript.
loading
Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells.
Johnson, Fraser D; Ferrarone, John; Liu, Alvin; Brandstädter, Christina; Munuganti, Ravi; Farnsworth, Dylan A; Lu, Daniel; Luu, Jennifer; Sihota, Tianna; Jansen, Sophie; Nagelberg, Amy; Shi, Rocky; Forcina, Giovanni C; Zhang, Xu; Cheng, Grace S W; Spencer Miko, Sandra E; de Rappard-Yuswack, Georgia; Sorensen, Poul H; Dixon, Scott J; Guha, Udayan; Becker, Katja; Djaballah, Hakim; Somwar, Romel; Varmus, Harold; Morin, Gregg B; Lockwood, William W.
Afiliação
  • Johnson FD; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada; Interdisciplinary Oncology Program, University of British Columbia, Vancouver, BC, Canada; Canada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, Vancouver, BC, Canada.
  • Ferrarone J; Meyer Cancer Centre, Weill Cornell Medicine, New York City, NY, USA.
  • Liu A; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.
  • Brandstädter C; Department of Biochemistry and Molecular Biology, Justus Liebig University Giessen, Giessen, Germany.
  • Munuganti R; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Farnsworth DA; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada; Interdisciplinary Oncology Program, University of British Columbia, Vancouver, BC, Canada.
  • Lu D; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada; Interdisciplinary Oncology Program, University of British Columbia, Vancouver, BC, Canada.
  • Luu J; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Sihota T; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Jansen S; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.
  • Nagelberg A; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Shi R; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada; Interdisciplinary Oncology Program, University of British Columbia, Vancouver, BC, Canada.
  • Forcina GC; Department of Biology, Stanford University, Stanford, CA, USA.
  • Zhang X; Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Cheng GSW; Canada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, Vancouver, BC, Canada.
  • Spencer Miko SE; Canada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, Vancouver, BC, Canada.
  • de Rappard-Yuswack G; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.
  • Sorensen PH; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Dixon SJ; Department of Biology, Stanford University, Stanford, CA, USA.
  • Guha U; Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Becker K; Department of Biochemistry and Molecular Biology, Justus Liebig University Giessen, Giessen, Germany.
  • Djaballah H; High Throughput Screening Core Facility, Memorial Sloan-Kettering Cancer Center, New York City, NY, USA; Keren Therapeutics, New York City, NY, USA.
  • Somwar R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
  • Varmus H; Meyer Cancer Centre, Weill Cornell Medicine, New York City, NY, USA.
  • Morin GB; Canada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, Vancouver, BC, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
  • Lockwood WW; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada; Interdisciplinary Oncology Program, University of British Columbia, Vancouver, BC, Canada; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada. Electronic add
Cell Rep ; 38(6): 110343, 2022 02 08.
Article em En | MEDLINE | ID: mdl-35139387
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxirredutases / Tiorredoxina Dissulfeto Redutase / Estresse Oxidativo / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxirredutases / Tiorredoxina Dissulfeto Redutase / Estresse Oxidativo / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2022 Tipo de documento: Article